Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy

Androgen deprivation therapy (ADT) is a cornerstone of treatment for prostate cancer and, in recent years, androgen receptor (AR)-targeted therapies (abiraterone and enzalutamide) have both been used for the treatment of castration-resistant prostate cancer (CRPC). In our study, we sought to investi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med
Main Authors: Conteduca, Vincenza, Caffo, Orazio, Scarpi, Emanuela, Sepe, Pierangela, Galli, Luca, Fratino, Lucia, Maines, Francesca, Chiuri, Vincenzo Emanuele, Santoni, Matteo, Zanardi, Elisa, Massari, Francesco, Toma, Ilaria, Lolli, Cristian, Schepisi, Giuseppe, Sbrana, Andrea, Kinspergher, Stefania, Cursano, Maria Concetta, Casadei, Chiara, Modonesi, Caterina, Santini, Daniele, Procopio, Giuseppe, De Giorgi, Ugo
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7356925/
https://ncbi.nlm.nih.gov/pubmed/32580478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9061950
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados